Cart
sales@molnova.com
Lateritin
CAS No. 65454-13-9
Lateritin( Bassiatin )
Catalog No. M27818 CAS No. 65454-13-9
Lateritin is An Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor and a platelet aggregation inhibitor from the mycelial cake of Gibberella lateritium. Bassiatin is the (3S,6R) isomer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 578 | Get Quote |
|
| 10MG | 822 | Get Quote |
|
| 25MG | 1233 | Get Quote |
|
| 50MG | 1665 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLateritin
-
NoteResearch use only, not for human use.
-
Brief DescriptionLateritin is An Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor and a platelet aggregation inhibitor from the mycelial cake of Gibberella lateritium. Bassiatin is the (3S,6R) isomer.
-
DescriptionLateritin is An Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor and a platelet aggregation inhibitor from the mycelial cake of Gibberella lateritium. Bassiatin is the (3S,6R) isomer.
-
In Vitro——
-
In Vivo——
-
SynonymsBassiatin
-
PathwayOthers
-
TargetOther Targets
-
RecptorElastase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number65454-13-9
-
Formula Weight261.321
-
Molecular FormulaC15H19NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)C1OC(=O)C(Cc2ccccc2)N(C)C1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hildreth, J.E.K. N-D-Gluco-N-methylalkanamide compounds, a new class of non-ionic detergents for membrane biochemistry. Biochem. J. 207(2), 363-366 (1982).
molnova catalog
related products
-
Leucokinin IV
Leucokinin IV
-
Anti-inflammatory ag...
Anti-inflammatory agent 49 is a potent inhibitor of Drp1-Fis1 interaction, inhibits GTPase, and can be used in the study of diseases caused by mitochondrial dysfunction.
-
KT-474
KT-474 (KYM-001) is a PROTAC degrader targeting interleukin-1 receptor-associated kinase 4 (IRAK4) with antitumor activity for the study of autoimmune, inflammatory, and cardiovascular disease disorders.
